MYOV | Myovant Sciences Ltd.
Category: Company
Quick infos Headquarters: United Kingdom Trade prices Volume: Market Cap: 1.24B Prev closed: 16.67 Open: 17 High: 17.73 Low: 16.75 52 week low: 4.14 52 week high: 19.58 Dividends: No Dividends Next ER: February 1, 2023 After Market Closes
Company Profile We aspire to be the leading healthcare company focused on innovative treatments for women?s health and prostate cancer designed to improve the lives of millions.
Earnings History Date EPS / Forecast Revenue / Forecast May 24, 2023 January 26, 2023 -0.59 / -0.4672100.23M / 107.83MNovember 16, 2022 - / -0.4825- / 93.73MOctober 26, 2022 -0.47 / -0.4704104.82M / 100.21MBeat! July 27, 2022 -0.22 / -0.304116.49M / 92.5MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 12, 2022 18.49 17.75 18.84
17.75
905.43K 4.46% Aug 11, 2022 17.70 17.65 18.08
17.28
1.30M 0.57% Aug 10, 2022 17.60 16.98 17.68
16.25
969.45K 5.52% Aug 9, 2022 16.68 16.17 16.94
15.55
1.40M 6.45% Aug 8, 2022 15.67 16.41 17.50
15.39
2.26M 3.64% Aug 5, 2022 15.12 14.41 15.27
14.14
725.18K 3.21% Aug 4, 2022 14.65 14.30 14.94
13.91
886.20K 3.31% Aug 3, 2022 14.18 14.12 14.75
13.88
645.48K 2.83% Aug 2, 2022 13.79 13.32 13.99
13.32
471.40K 4.23% Aug 1, 2022 13.23 13.12 13.83
12.86
804.66K 1.15% view more
NYSE - New York Stock Exchange
More profiles and info about the company Founded:2016 Employees:167 Parent Organization : Roivant Sciences, Sumitovant Biopharma Ltd. News
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares finance.yahoo.com Oct 27, 2022 7:36 pm
Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat? finance.yahoo.com Oct 27, 2022 5:32 pm
Myovant Sciences Cancels Second Quarter Earnings Conference Call finance.yahoo.com Oct 27, 2022 4:30 pm
Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 finance.yahoo.com Oct 27, 2022 4:05 pm
FDA Finds Deficiencies in Myovant (MYOV), Pfizer's Myfembree sNDA finance.yahoo.com Oct 27, 2022 2:47 pm Myovant Sciences Rejects $2.5 Billion Takeover; Now What? thestreet.com Oct 27, 2022 1:54 pm
Sumitomo Unit Agrees to Buy Myovant After Increasing Offer finance.yahoo.com Oct 27, 2022 9:45 am
Myovant Stock Leaps After Rejecting $2.5 Billion Sumitomo Bid barrons.com Oct 27, 2022 8:26 am
Myovant Sciences (MYOV) Reports Q3 Loss, Misses Revenue Estimates finance.yahoo.com Oct 27, 2022 8:15 am Myovant Sciences shares trading higher after agreeing to Sumitomo deal for $2.9 billion marketwatch.com Oct 27, 2022 8:12 am
Tesla, Credit Suisse Fall Premarket; Wells Fargo, Viasat, Box Rise finance.yahoo.com Oct 27, 2022 3:52 am CORRECTED-UPDATE 2-Japan's Sumitomo Pharma to buy rest of Myovant for $27 per share finance.yahoo.com Oct 27, 2022 12:04 am
Myovant Sciences (MYOV) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com Oct 26, 2022 9:45 am
Myovant Sciences Accepts Slightly Higher Takeover Offer thestreet.com Oct 24, 2022 8:13 pm Myovant climbs 32% after rejection of $2.4B buyout offer seekingalpha.com Oct 3, 2022 7:42 pm
Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid investors.com Oct 3, 2022 4:06 pm Myovant Sciences rejects Sumitovant Biopharma's $2.4 billion takeover offer seekingalpha.com Oct 3, 2022 8:33 am Myovant stock soars after confirming buyout bid, but said it 'significantly undervalues' the company marketwatch.com Oct 3, 2022 6:42 am
UPDATE 1-Myovant Sciences rejects $2.5 bln takeover bid from Sumitovant, Sumitomo Pharma finance.yahoo.com Oct 2, 2022 8:40 pm The prostate cancer therapy market will soar. Here are the companies that could benefit. seekingalpha.com Sep 26, 2022 2:00 am This company doesn't provide a dividend.
Key Persons CEO : Lynn Seely Corporate Secretary : Matthew Lang Talk about Myovant Sciences Ltd. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
